2Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets [J]. Cancer, 1987, 59(8) :1442 -54.
3Ogose A, Hotta T, Emura I, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia[J]. Skeletal Radiol, 2001, 30(2) :99 - 103.
4Folpe A L, Fanburg-Smith J C, Billings S D, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol, 2004, 28(1) :1 -30.
5De Beur S M, Finnegan R B, Vassiliadis J, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism[J]. J Bone Miner Res, 2002, 17(6) : 1102 - 10.
6John M R, Wickert H, Zaar K, et al. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma [J]. Bone, 2001, 29(4):393 -402.
7Nelson A E, Hogan J J, Holm I A, et al. Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties[J]. Bone, 2001, 28(4) :430 -9.
8Bowe A E, Finnegan R, Jan de Beur S M, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate [J]. Biochem Biophys Res Commun, 2001, 284(4) :977 - 81.
9Mirams M, Robinson B G, Mason R S, et al. Bone as a source of FGF23 : regulation by phosphate? [J]. Bone, 2004, 35(5): 1192 -9.
10Larsson T, Zahradnik R, Lavigne J, et al. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia[J]. Eur J Endocrinol, 2003, 148 (2) :269 - 76.
